Labshake search
Citations for Bio X Cell :
151 - 200 of 219 citations for 4 1BBR TNFRSF9 Human HEK293 Fc since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... 750 μg of anti-CTLA-4 antibody clone UC10-4F10-11 (Bio X Cell) or hamster IgG isotype control antibody (clone PIP ...
-
bioRxiv - Immunology 2023Quote: ... and 4 dpi with 250µg in 200µL of αLy6G antibody (Clone 1A8 IgG2a, BioXCell) or with isotype control antibody (BioXCell ...
-
bioRxiv - Immunology 2019Quote: ... CA); anti-human CD3ε (OKT3, BE0001-2; RRID:AB_1107632) and CD28 (9.3, BE0248; RRID:AB_2687729) from Bio X Cell (Lebanon, NH); anti-human TCR Vβ8 (C305 ...
-
bioRxiv - Immunology 2021Quote: ... Recipient mice were treated IV with 400 μg of anti-human CD2 monoclonal antibody [29] (Bio X Cell, Inc) by intravenous injection on days 0 ...
-
bioRxiv - Neuroscience 2020Quote: Neutralizing anti-IL-4 antibody (11B11 clone) was purchased from BioXcell (West Lebanon, NH, USA). A subset of mice underwent i.p ...
-
bioRxiv - Cancer Biology 2019Quote: ... an additional group (n=4) was injected with 250μg anti-CD25 antibody (PC-61.5.3, BioXCell). One saline group (n=5 ...
-
bioRxiv - Immunology 2023Quote: ... or anti-CTLA-4 (200 μg/100 μL; clone 9D9; cat. #BE0164; Bio X Cell) or anti-LAG-3 (200 μg/100 μL ...
-
bioRxiv - Immunology 2023Quote: ... 100 µg/ml of anti-CTLA-4 antibody (clone UC10-4F10-11, Bio X Cell) or 25 nM Bafilomycin A1 (Sigma-Aldrich ...
-
bioRxiv - Immunology 2023Quote: ... and 10 μg/ml of anti-IL-4 mAb (Bio X Cell Cat# BE0045 RRID:AB_1107707); (c ...
-
bioRxiv - Immunology 2023Quote: Mice were injected intraperitoneally with anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and anti- PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Cancer Biology 2024Quote: ... Anti-murine PD-1 and anti-murine CTLA-4 were purchased from Bio X Cell (BE0146-clone RMP1-14 ...
-
bioRxiv - Cancer Biology 2020Quote: ... MDS patient BM CD34-selected cells were incubated with a murine anti-human CD3 antibody (clone Okt3, BioXCell, NH, USA) at 5□µg/100□µl for 10□min at room temperature prior to injection ...
-
bioRxiv - Immunology 2022Quote: ... were injected on day −3 (prior to intranasal viral challenge with 1 x 103 PFU of Delta SARS-CoV-2 (B1.617.2)) intraperitoneally with 30mg/kg GAR05 and a human IgG1 isotype control (Bio X Cell) at 3mg/ml in PBS ...
-
bioRxiv - Immunology 2021Quote: ... CTLs were pre-incubated with LFA-1 blocking antibody (20 μg/mL, Clone M17/4, BioXCell) or an IgG2aκ isotype control antibody (20 μg/mL ...
-
bioRxiv - Immunology 2020Quote: Mice were injected intraperitoneally with 200 μg with anti-IL-4 (clone 11B11, Bio X Cell) or Rat IgG1 isotype control (clone HRPN ...
-
bioRxiv - Immunology 2022Quote: ... or combination of PD-1 and CTLA-4 using anti-PD-1 (clone: RMP1-14, BioXcell), anti-CTLA-4 (clone ...
-
bioRxiv - Immunology 2023Quote: ... 4 dpi with 300 µg in 200 µL of αCXCL9 antibody (Clone MIG-2F5.5 IgG, BioXCell).
-
bioRxiv - Cancer Biology 2022Quote: Antibodies used for in vivo treatment and blocking and for in vitro phagocytosis are as follows: anti-mouse/human Tyrp1 clone TA99 (BioXCell BE0151), mouse IgG2a isotype control clone C1.18.4 (BioXCell BE0085 ...
-
bioRxiv - Bioengineering 2023Quote: ... a total of 10 μg of antibody consisting of 2 μg of anti-human CD3 antibody (Bio X Cell, BE0001-2) and 8 μg of experimental antibody in 1 mL of 1X PBS was incubated at room temperature for 2 days with rotation ...
-
bioRxiv - Cancer Biology 2024Quote: Antibodies used for in vivo treatment and blocking and for in vitro phagocytosis are as follows: anti-mouse/human Tyrp1 clone TA99 (BioXCell BE0151), mouse IgG2a isotype control clone C1.18.4 (BioXCell BE0085) ...
-
bioRxiv - Immunology 2019Quote: ... mice were treated with InVivoMAb anti-mouse Thy1.2 (200ug/mice for 4 consecutive days, Clone 30H12, BioXCell). Experiments were performed 6-7 weeks after the last treatment with α-Thy1.2.
-
bioRxiv - Immunology 2021Quote: ... mice were treated with 200μg of CD71 blocking antibody (clone R17 217.1.3/TIB-219) or an isotype control antibody starting at 4-4.5 months of age (BioxCell). Treatment was administered twice a week via IP injection for 4 weeks.
-
bioRxiv - Immunology 2023Quote: ... Py - infected mice were treated intraperitoneally with either 50 μg of anti-4-1BB antibody (3H3; BioXCell) or Rat IgG (rIgG ...
-
bioRxiv - Bioengineering 2021Quote: ... using 100 μg of pan-specific anti-human MHC Class I (HLA-A, HLA-B, HLA-C) antibody (clone W6/32, Bio X Cell) per 1e6 cells ...
-
bioRxiv - Immunology 2022Quote: ... were injected on day −3 (prior to intranasal viral challenge with 1 x 103 PFU of Wuhan SARS-CoV-2 (Isolate AUS/VIC01/2020)) intraperitoneally with 30mg/kg for each individual antibody (GAR05, GAR12, GAR20 and a human IgG1 isotype control (Bio X Cell) at 3mg/ml in PBS ...
-
bioRxiv - Immunology 2022Quote: ... were injected on day 1 (post intranasal viral challenge with 1 x 103 PFU of Wuhan SARS-CoV-2 (Isolate AUS/VIC01/2020)) intraperitoneally with 30mg/kg GAR05 or a human IgG1 isotype control (Bio X Cell) at 3mg/ml in PBS ...
-
bioRxiv - Immunology 2022Quote: ... Cells were subsequently washed twice with PBS and incubated with anti-human ICAM-1-AlexaFluor647 (BioXcell, BE0020-2, 3 µM, 1:500 dilution) for 30 min at room temperature ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were then treated for 30 min at 4°C with 50 µL per well of 10 µg/mL of InVivoMAb anti-human CD47 (clone B6.H12; #BE0019-1, Bio X Cell, USA) or InVivoMAb mouse IgG1 isotype control (clone MOPC-21 ...
-
bioRxiv - Immunology 2020Quote: ... The PBMCs were stimulated with 4 μg/mL plate-bound anti-CD3 antibody (clone OKT3; Bio X cell), 2 μg/mL soluble anti-CD28 antibody (clone CD28.2 ...
-
bioRxiv - Immunology 2021Quote: Intraperitoneal injections of αPDL1 (200 μg/injection on days 4, 8, 14, and 18; clone 10F.9G2; BioXcell), and HMGN1 and its-derived peptdies (0.08 μg on days 9 ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Bioengineering 2023Quote: ... anti-mouse CTLA-4 (BE0131) and anti-mouse PD-L1 (BE0101) antibodies were purchased from Bioxcell (Lebanon, NH). Anti-human PD-L1 antibody (10084-R639) ...
-
bioRxiv - Cancer Biology 2022Quote: ... 0.5 mg of pan-specific anti-human MHC Class I (HLA-A, HLA-B, HLA-C) antibody (clone W6/32, Bio X Cell [cat # BE0079]) was bound to 20 μL FastFlow Protein A Sepharose bead slurry (GE Healthcare ...
-
bioRxiv - Immunology 2019Quote: ... The PBMCs were stimulated with 4 μg/mL of plate-bound anti-CD3 antibody (clone OKT3; Bio X cell), 2 μg/mL of soluble anti-CD28 antibody (clone CD28.2 ...
-
bioRxiv - Immunology 2020Quote: ... Mice were injected with 100µg of anti–CTLA-4 mAb (#BE0164, clone 9D9, Bio X Cell, West Lebanon, NH) or isotype control (#BE0086 ...
-
bioRxiv - Immunology 2022Quote: ... and then transferred to a 96 well plate that had been coated overnight at 4°C with 5µg/ml αCD3 (BE0001-1, BioXcell), 5µg/ml CD80-Fc (555404 ...
-
bioRxiv - Immunology 2022Quote: ... cells were stained in the dark for 20 minutes at 4°C with fluorochrome- or biotin-conjugated antibodies in PBS containing anti-CD16/CD32 (2.4G2; BioXcell) in the dark ...
-
bioRxiv - Immunology 2022Quote: ... Cells were washed in PBS followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing anti-CD16/32 (clone 2.4G2; BioXCell) to block non-specific binding ...
-
bioRxiv - Immunology 2022Quote: For checkpoint blockade therapy 100 μg each of anti-CTLA-4 (Clone UC10-4F10-11, Bio X Cell BP0032) and anti-PD-L1 (Clone 10F.9G2 ...
-
bioRxiv - Microbiology 2023Quote: ... the cells were incubated with a primary antibody against LCMV NP (VL-4, Bio X Cell, Lebanon, NH, USA), followed by a secondary anti-rat IgG antibody conjugated with Alexa Fluor 568 (anti-rat-AF568 ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Biochemistry 2019Quote: ... 1 mM STF-1084 in PBS or PBS alone were injected intratumorally and 200 μg of anti-CTLA-4 antibody or Syrian hamster IgG antibody (both BioXCell) were injected intraperitoneally on day 2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 200 μg of ◻PD-L1 (10F.9G2) or αPD-1 (RMP1-14) or αCTLA-4 (9H10) antibody or with isotype control antibodies (all from BioXcell) on days 9 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Immunology 2020Quote: ... The following soluble TNFRSF agonists were used to co-stimulate Tregs: anti-4-1BB mAb (10 μg/ml, 3H3, BioXcell), OX40L (100 ng/ ml ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were washed with PBS followed by surface staining at 4 °C with directly conjugated antibodies (see list below) diluted in FACS buffer containing anti-CD16/32 (BioXCell, BE0307 ...
-
bioRxiv - Immunology 2023Quote: ... into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems) plus anti-IL-4 (10 μg mL-1, BioXcell), or Th17 – rhTGFβ (3 ng mL-1 ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...